Kiniksa Pharmaceuticals International PLC (KNSA)

NASDAQ · Biotechnology

79.30
+0.12 (+0.15%)
Updated Aug 18, 6:05 PM ET
AI Rating
Hold
Overall Score
59
Trend
75
Momentum
64
Risk
28

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Kiniksa Pharmaceuticals International PLC is trading at $79.30, up 0.15% on the session. The 50 day average sits at $63.98 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 62.2, which reads as strong, and MACD is bearish crossover. Volume is below average.

The nearest support is around $75.00 with resistance near $78.80, so that band frames the current range. Average daily movement is roughly $3.23, or about 4.1% of the share price, which is what any stop placement has to allow for. The overall health score of 59 out of 100 combines a trend score of 75, momentum of 64 and a risk score of 28.

Technical indicators

RSI (14)
62.2
strong
MACD
4.081
bearish crossover
SMA 20
72.90
SMA 50
63.98
SMA 200
--
unknown
ATR (14)
3.23
avg daily range
Support
75.00
Resistance
78.80
Volume vs 20d
0.57x
below average
Volatility
86.7%
annualised
1 month
+25.59%
3 months
+31.11%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.